• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchResponse Genetics
    Picture of Response Genetics logo

    RGDXQ — Response Genetics Share News

    $0.000.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      $0.00m
    • Enterprise Value
      $9.21m
    • Revenue
      $16.72m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • RGDXQ Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    RGDXQ Dividends
    • ASX-listed Roto-Gro gains as Canniberia pre-approval triggers first order

      06/09/2021 07:18
    • Brief: Response Genetics entered third amendment to credit agreement dated July 30, 2014

      01/07/2015 21:08
    • Brief: Response Genetics Q4 loss per share $0.09

      31/03/2015 21:05
    • Brief: Response Genetics secures New York state department of health approval for testing services

      11/12/2014 12:03
    • Brief: Response Genetics Q3 loss per share $0.09

      13/11/2014 12:00
    • Market Pulse: Intel, Qualcomm, Adobe, Anadarko, Atossa, Adamis

      13/12/2013 15:26

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.